3Settimana·

New addition

$NOVO B (-7,73%)
$NVO (-7,33%)

First entry

26.03

Novo Nordisk

Acquistato x20 a 68,19 €

1363,80 €

7 Commenti

Marto@Maddy-0

3Settimana

Some against out, others against in, opinions are divided on this company 😂
Unfortunately, I currently still have an internal combustion engine

•

Bubu@Bubu_98

3Settimana

Top in the long term! Uncertain in the short term.

I hope we continue to dip then I can build up my position over the next few months.

With the next positive catalysts, the share should turn sharply again 📈💪

•

fund_mastermind_1958@fund_mastermind_1958

3Settimana

@Bubu_98 wdym with long term? years?

•

Bubu@Bubu_98

3Settimana

@fund_mastermind_1958 years, decades

•

Mixxed U.@Mixxed

3Settimana

-18% 😀

•

CD@Carpe-Diem

3Settimana

I see the following problems with this company: 1. hype - everyone is talking about it. 2. simple product, nothing special. 3. thousands of competitors tackling a very common problem - diabetes and obesity are not new.

••

Patrick@Pazi3

3Settimana

@Carpe-Diem

I agree with you on point 3.

Point 1) Yes and no. There was a certain amount of hype, but the share is currently only falling in one direction. I think the hype is over. For the time being.

2) Is the product really that simple?
I see a product that is still in its infancy (in terms of weight loss medication). Study targets are constantly being missed & many are only just entering the market. I think a lot will develop in the next few years.

$LLY & $NOVO B are the big players in this field & are unable to meet demand. I am therefore positive 😉

Let's see what happens

•